Kyntra Bio (KYNB) FCF Margin (QoQ) (2014 - 2026)
Kyntra Bio (KYNB) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Kyntra Bio | 30.42 Mn | 30.42 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,006.00 |
| Mar 31, 2026 | 106,373.00 |
| Dec 31, 2025 | -126,275.00 |
| Sep 30, 2025 | -111,233.00 |
| Jun 30, 2025 | 84,115.00 |
| Mar 31, 2025 | 107,499.00 |
| Dec 31, 2024 | 590,012.00 |
| Sep 30, 2024 | 309,433.00 |
| Jun 30, 2024 | -727,452.00 |
| Mar 31, 2024 | -271,812.00 |
| Dec 31, 2023 | 23,423.00 |
| Sep 30, 2023 | 56,241.00 |
| Jun 30, 2023 | 523,596.00 |
| Mar 31, 2023 | -542,103.00 |
| Dec 31, 2022 | -25,447.00 |
| Sep 30, 2022 | -22,124.00 |
| Jun 30, 2022 | -1,076.00 |
| Mar 31, 2022 | 23,746.00 |
| Dec 31, 2021 | -36,803.00 |
| Sep 30, 2021 | 14,327.00 |